ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment - Candlesense
KROS Governance

ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment

AUSTIN, Texas, Aug. 21, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "we"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today released...

Related Questions

How will ADAR1's push for strategic and capital allocation changes influence Keros' short‑term stock price? What potential board refreshment actions could alter Keros' governance structure and affect its long‑term growth prospects? How might the market view ADAR1's 13.3% stake and activism in terms of future dilution or financing needs?
Find similar articles on Candlesense prnewswire